Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Adding aesthetic therapies to medications doesn't improve male pattern baldness treatment.

B6J mice live longer before 24 months, but B6N mice live longer after; both strains show weight gain, increased food and water intake, and health issues as they age.

Home-use cosmetic laser and light devices show modest results for hair removal and acne treatment, but more research is needed for confirmation.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

The Polish version of the Alopecia Areata Quality of Life Index is a reliable tool for assessing quality of life in Polish-speaking patients with alopecia areata.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

The herbal extract is as effective and safe as 3% minoxidil for treating hair loss.

Effective vaccines and treatments are crucial for long-term COVID-19 control.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

70.7% of patients had long-COVID symptoms like fatigue, cough, and brain fog three months after recovery.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

The treatment effectively reduces menopausal symptoms and is well tolerated.

Microemulsions could improve skin drug delivery but face challenges like complex creation and potential toxicity.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Women are more likely to have long-term post-COVID symptoms than men.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

ABCG2 protein marks stem-like skin cells in human epidermis.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Monocytes might be linked to hair loss after COVID-19.

Hormone levels in hair vary across the head, with the highest concentration of a key hormone linked to hair loss at the top.

Long COVID sufferers face significant challenges that need more public awareness and support.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.